|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||4.8937 - 5.1000|
|52 Week Range||3.4580 - 10.4404|
|Beta (3Y Monthly)||0.32|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The next five days will still be full of news surrounding the cannabis space. We have compiled a list of main things that cannabis investors should be keeping an eye on this week. Ontario Lottery And New ...
TORONTO , Aug.15, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to share that its portfolio companies, James E. Wagner Cultivation Corporation ("JWC") (JWCA.V) (JWCAF) and TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF), have entered into a purchase and supply agreement, demonstrating the type of collaboration and synergy seen throughout the Canopy Rivers ecosystem. As part of the agreement, JWC will supply cannabis flower and oils to TerrAscend, which will be made available for purchase on TerrAscend's online medical sales platform, Solace Health, providing JWC with exposure to thousands of registered medical patients across Canada .
OTCQX: TRSSF), pursuant to which the Corporation agreed to provide dry cannabis flower and cannabis oils to TerrAscend (the “Agreement”). It is anticipated that the Purchaser will list the product acquired from JWC under the Agreement for sale on its online medical sales platform, the Solace Health online marketplace, once inaugural product inventories have been received. With this Agreement, JWC will have access to two of the largest medical store fronts in Canada.
OTCQX: TRSSF) ("TerrAscend" or the "Company"), the first and only cannabis company licensed for sales in Canada , the US, and the EU, today announced that it has completed its first international shipment of dry cannabis flower to its German distribution partner iuvo Therapeutics GmbH ("iuvo"). The shipment was made from TerrAscend's EU GMP certified manufacturing facility in Mississauga, Ontario , Canada. As the Company ships additional product to Germany in partnership with iuvo, it will continue to expand its footprint in Europe and other international markets. The Company looks forward to providing investors with updates on such expansion activities. TerrAscend and iuvo, respectively were granted an Export Permit by Health Canada, under the Cannabis Act, and an Import Authorization from Germany's Federal Institute for Drugs and Medical Devices, following the issuance of the Company's EU Good Manufacturing Practice ("GMP") certificate on April 29 , 2019. TerrAscend is one of only six companies with a GMP certified cannabis facility.
Canada-based TerrAscend Corp (OTC:TRSSF) (CSE:TER), the first licensed for sales in Canada, the U.S. and the E.U., announced this week it's acquiring Ilera Healthcare, one of the five vertically-integrated cannabis cultivators, processors and dispensary operators in Pennsylvania. Subject to regulatory approval, the company will buy Ilera for total consideration of $125 million to $225 million, which will be paid in a combination of cash and TerrAscend shares. TerrAscend is a portfolio company of Canopy Rivers Inc (OTC: CNPOF), the investment arm of Canopy Growth Corp (NYSE: CGC).
LONDON, ON , Aug. 7, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (NDVA.V) (NDVAF) and TerrAscend (CSE:TER) (TRSSF) are pleased to announce the signing of an agreement to partner on an extraction services program (the "Agreement"). Under the terms of the Agreement, Indiva will provide TerrAscend with extraction and refinement support at its state-of-the-art facility in London, Ontario .
TORONTO , Aug. 6, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to announce its portfolio company, TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF), has signed a definitive agreement to acquire Ilera Healthcare ("Ilera"), a vertically-integrated cannabis cultivator, processor, and dispensary operator in Pennsylvania . Ilera's state-of-the-art, fully integrated seed-to-sale operations adds to TerrAscend's growing global footprint, currently spanning multiple U.S. states, Canada and the European Union. "TerrAscend's rapid expansion in the U.S. has been driven by strategic, accretive acquisitions of quality operators with strong track records of success," said Narbe Alexandrian, President and CEO of Canopy Rivers.
--- Ilera's current revenue run-rate is over US$43 million 1, up from total sales in 2018 of less than US$8 million 1. --- State-of-the-art, fully integrated seed-to-sale operator in Pennsylvania adds to TerrAscend's global portfolio of operations across multiple U.S. States, Canada and the EU. --- Ilera's team members will continue in their current roles and join TerrAscend's rapidly expanding US operations.
OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only cannabis company licensed for sales in Canada , the US, and Europe is pleased to congratulate the team at PharmHouse Inc. ("PharmHouse") on securing a cannabis cultivation licence from Health Canada. The licence allows PharmHouse to begin cultivating and supplying cannabis from its 1.3 million square foot greenhouse (the "Facility") located in Leamington, Ontario .
TORONTO , July 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) congratulates its portfolio company TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF) on its announcement today that it has received an amendment to its licence from Health Canada allowing for the sale of cannabis oils from its facility in Mississauga, Ontario . This news comes two months following TerrAscend's announcement that it had been issued a Good Manufacturing Practice (GMP) certificate in accordance with the rules governing medical products in the European Union, in conjunction with establishing a sales and distribution agreement with iuvo Therapeutics GmbH, a German pharmaceutical wholesaler. "With another key milestone achieved by TerrAscend in a matter of a few short months, the company continues to demonstrate its ambition to become a global provider of pharmaceutical-grade cannabis products," said Narbe Alexandrian, President and CEO of Canopy Rivers.
OTCQX: TRSSF) ("TerrAscend" or the "Company") today announced that its subsidiary, TerrAscend Canada, has received an amendment to its license from Health Canada to allow it to sell cannabis oils from its EU-GMP certified facility in Mississauga, Ontario. Sales of TerrAscend's cannabis oils will begin immediately through its medical marketplace, Solace Health (www.solacehealth.com), and to the Canadian adult use market in the coming weeks. The Company is also pursuing export of its oils to international medical markets and will share news of these milestones as it achieves them.
OTCQX: TRSSF) ("TerrAscend" or the "Company") has closed a series of transactions to acquire the California operations of the award-winning retail dispensary brand known as "The Apothecarium" for consideration comprised of US$36.8 million in cash and proportionate voting shares in the equity of TerrAscend equivalent to 6.7mm common shares of the Company. The transactions include three entities operating the San Francisco locations of The Apothecarium, two additional retail locations, and Valhalla Confections, a leading provider of premium edible products.
OTCQX: TRSSF) ("TerrAscend" or the "Company") is pleased to announce that the nominees set forth in the Company's management information circular dated April 24, 2019 , Mr. Craig Collard , Mr. Richard Mavrinac , Dr. Michael Nashat , Ms. Lisa Swartzman and Mr. Jason Wild , were elected as directors of the Company at the annual meeting of shareholders held today (the "Meeting"). At the Meeting, shareholders also approved the re-appointment of MNP LLP as the auditor of the Company and the authorization of the Company's board of directors to fix the auditor's remuneration.
Cannabis cultivator TerrAscend Corp. (CSE:TER)(OTC: TRSSF ) reported the completion of its previously announced non-brokered private placement. Orders totaled an approximate CA$69 million (about $93 million ...